SCHEMBL3620171

SCHEMBL3620171

COCCOS(=O)(=O)c1ccccc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
ESR1 P03372 2/20 0.41
ESR2 Q92731 2/20 0.41
GAA P10253 2/20 0.41
POLB P06746 1/20 0.40
ALDH1A1 P00352 4/20 0.39
ATM Q13315 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP2C9 P11712 1/20 0.38
CYP2C19 P33261 1/20 0.38
ALOX12 P18054 1/20 0.38
HTT P42858 1/20 0.38
RAPGEF4 Q8WZA2 1/20 0.37
TSHR P16473 1/20 0.37
CA2 P00918 1/20 0.36
MAPK1 P28482 1/20 0.36
RXFP1 Q9HBX9 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
HTR6 P50406 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8961970 0.95 MEN1 (0.39) KMT2AMEN1ESR1ESR2GAA
SCHEMBL8654494 0.93 KMT2A (0.45) KMT2AMEN1ESR1ESR2GAA
SCHEMBL7619544 0.85 KMT2A (0.43) KMT2AMEN1ESR1ESR2GAA
SCHEMBL6411427 0.84 KMT2A (0.42) KMT2AMEN1ESR1ESR2GAA
SCHEMBL6916199 0.84 KMT2A (0.42) KMT2AMEN1ESR1ESR2GAA
SCHEMBL8746193 0.82 GAA (0.48) KMT2AMEN1ESR1ESR2GAA
SCHEMBL71839 0.82 KMT2A (0.41) KMT2AMEN1ESR1ESR2GAA
SCHEMBL2762565 0.82 KMT2A (0.41) KMT2AMEN1ESR1ESR2GAA
Hydrochloric Acid SCHEMBL27691765 0.82 KMT2A (0.41) KMT2AMEN1ESR1ESR2GAA
SCHEMBL28577594 0.81 CA12 (0.43) KMT2AMEN1ESR1ESR2GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117855603-A Nonaqueous electrolyte, preparation method thereof and lithium ion battery 惠州市豪鹏科技有限公司 2024-04-09 CN disclosed
EP-2766345-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS Bristol-Myers Squibb Company (US) 2014-08-20 EP disclosed
EP-1677822-B1 4'-THIONUCLEOSIDES AND OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2014-04-23 EP disclosed
WO-2013055984-A1 SUBSTITUTED TETRAHYDROISOQUINOLINE COMPOUNDS AS FACTOR XIA INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2013-04-18 WO disclosed
WO-2012066065-A1 PHENYL-HETEROARYL AMINE COMPOUNDS AND THEIR USES NOVARTIS AG (CH) 2012-05-24 WO disclosed
WO-2010090860-A2 METHODS AND COMPOSITIONS FOR TREATING BACTERIAL INFECTION THE REGENTS OF THE UNIVERSITY OF MICHIGAN (US) 2010-08-12 WO disclosed
EP-1677822-A4 4'-THIONUCLEOSIDES AND OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2009-08-19 EP disclosed
WO-2005027962-A9 4’-THIONUCLEOSIDES AND OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS INC (US) 2006-08-10 WO disclosed
EP-1677822-A2 4'-THIONUCLEOSIDES AND OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 2006-07-12 EP disclosed
WO-2005027962-A1 4’-THIONUCLEOSIDES AND OLIGOMERIC COMPOUNDS ISIS PHARMACEUTICALS, INC. (US) 2005-03-31 WO disclosed